287 related articles for article (PubMed ID: 3111237)
1. Electrophysiologic and antiarrhythmic effects of oral encainide in patients with atrioventricular nodal reentry or nodoventricular reentry.
Miles WM; Chang MS; Heger JJ; Rinkenberger RL; Zipes DP; Prystowsky EN
Am Heart J; 1987 Jul; 114(1 Pt 1):26-33. PubMed ID: 3111237
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and electrophysiologic effects of encainide for atrioventricular nodal reentrant tachycardia.
Naccarelli GV; Jackman WM; Akhtar M; Rinkenberger RL; Friday KJ; Dougherty AH; Tchou P; Yeung-Lai-Wah JA
Am J Cardiol; 1988 Dec; 62(19):31L-36L. PubMed ID: 3144165
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic and clinical effects of oral encainide in paroxysmal atrioventricular node reentrant tachycardia.
Chimienti M; Li Bergolis M; Moizi M; Salerno JA
J Am Coll Cardiol; 1989 Oct; 14(4):992-8. PubMed ID: 2507613
[TBL] [Abstract][Full Text] [Related]
4. Role of adrenergic stimulation by isoproterenol in reversal of effects of encainide in supraventricular tachycardia.
Akhtar M; Niazi I; Naccarelli GV; Tchou P; Rinkenberger R; Dougherty AH; Jazayeri M
Am J Cardiol; 1988 Dec; 62(19):45L-49L. PubMed ID: 3144167
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
[TBL] [Abstract][Full Text] [Related]
6. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
[TBL] [Abstract][Full Text] [Related]
7. Treatment of atrioventricular node reentrant tachycardia with encainide: reversal of drug effect with isoproterenol.
Niazi I; Naccarelli G; Dougherty A; Rinkenberger R; Tchou P; Akhtar M
J Am Coll Cardiol; 1989 Mar; 13(4):904-10. PubMed ID: 2494243
[TBL] [Abstract][Full Text] [Related]
8. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.
Jackman WM; Friday KJ; Fitzgerald DM; Yeung-Lai-Wah JA; Lazzara R
Am J Cardiol; 1988 Dec; 62(19):8L-19L. PubMed ID: 3059792
[TBL] [Abstract][Full Text] [Related]
9. Encainide for treatment of atrioventricular reciprocating tachycardia in the Wolff-Parkinson-White syndrome.
Miles WM; Zipes DP; Rinkenberger RL; Markel ML; Prystowsky EN; Dougherty AH; Heger JJ; Naccarelli GV
Am J Cardiol; 1988 Dec; 62(19):20L-25L. PubMed ID: 3144163
[TBL] [Abstract][Full Text] [Related]
10. Ablation of atrioventricular nodal "slow pathway" for simultaneous treatment of coexisting atrioventricular and nodal reciprocating tachycardias.
Di Biase L; Bai R; Tritto M; Grimaldi M; Biasco MG
J Interv Card Electrophysiol; 2007 Aug; 19(2):143-7. PubMed ID: 17668304
[TBL] [Abstract][Full Text] [Related]
11. [Anti-arrhythmia and electrophysiological effects of encainide in supraventricular tachycardias].
Cassagneau B; Miquel JP; Puel JP; Mordant B; Kher A; Fauvel JM; Bounhoure JP
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():113-9. PubMed ID: 3938253
[TBL] [Abstract][Full Text] [Related]
12. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
[TBL] [Abstract][Full Text] [Related]
13. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
Kühlkamp V; Ickrath O; Haasis R; Seipel L
Z Kardiol; 1988 Aug; 77(8):527-33. PubMed ID: 3176596
[TBL] [Abstract][Full Text] [Related]
14. Atrioventricular block in the atypical form of junctional reciprocating tachycardia: evidence supporting the atrioventricular node as the site of reentry.
Yeh SJ; Yamamoto T; Lin FC; Wu D
J Am Coll Cardiol; 1990 Feb; 15(2):385-92. PubMed ID: 2299081
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
Prystowsky EN; Klein GJ; Rinkenberger RL; Heger JJ; Naccarelli GV; Zipes DP
Circulation; 1984 Feb; 69(2):278-87. PubMed ID: 6418407
[TBL] [Abstract][Full Text] [Related]
16. Cycle length alternation during supraventricular tachycardia: occurrence and mechanism in a canine model of AV reentrant tachycardia.
Talajic M; Villemaire C; Papadatos D; Lemery R; Roy D; Nattel S
Pacing Clin Electrophysiol; 1990 Mar; 13(3):314-25. PubMed ID: 1690404
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of adenosine on antegrade and retrograde fast pathway conduction in atrioventricular nodal reentry.
Lee CS; Lai WT; Wu JC; Sheu SH; Wu SN; Belardinelli L
Am Heart J; 1997 Nov; 134(5 Pt 1):799-806. PubMed ID: 9398091
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainide.
Helmy I; Scheinman MM; Herre JM; Sharkey H; Griffin JC
J Am Coll Cardiol; 1990 Dec; 16(7):1649-55. PubMed ID: 2123908
[TBL] [Abstract][Full Text] [Related]
19. AV nodal reentrant tachycardia using three different AV nodal pathways.
Kühlkamp V; Haasis R; Seipel L
Eur Heart J; 1990 Sep; 11(9):857-62. PubMed ID: 2226514
[TBL] [Abstract][Full Text] [Related]
20. Role of intravenous isoproterenol in the electrophysiologic induction of atrioventricular node reentrant tachycardia in patients with dual atrioventricular node pathways.
Huycke EC; Lai WT; Nguyen NX; Keung EC; Sung RJ
Am J Cardiol; 1989 Nov; 64(18):1131-7. PubMed ID: 2479251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
